- Home
- CVAC vs DOLE Comparison
CVAC vs DOLE Comparison
Compare CVAC & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- DOLE
- Stock Information
- Founded
- CVAC 2000
- DOLE 1851
- Country
- CVAC Germany
- DOLE Ireland
- Employees
- CVAC N/A
- DOLE N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- DOLE Farming/Seeds/Milling
- Sector
- CVAC Health Care
- DOLE Consumer Staples
- Exchange
- CVAC Nasdaq
- DOLE Nasdaq
- Market Cap
- CVAC 1.2B
- DOLE 1.3B
- IPO Year
- CVAC 2020
- DOLE 2021
- Fundamental
- Price
- CVAC $5.36
- DOLE $13.20
- Analyst Decision
- CVAC Hold
- DOLE
- Analyst Count
- CVAC 3
- DOLE 0
- Target Price
- CVAC $6.83
- DOLE N/A
- AVG Volume (30 Days)
- CVAC 411.0K
- DOLE 806.7K
- Earning Date
- CVAC 11-11-2025
- DOLE 11-12-2025
- Dividend Yield
- CVAC N/A
- DOLE 2.58%
- EPS Growth
- CVAC N/A
- DOLE N/A
- EPS
- CVAC 1.01
- DOLE 0.25
- Revenue
- CVAC $599,540,810.00
- DOLE $8,757,709,000.00
- Revenue This Year
- CVAC N/A
- DOLE $6.69
- Revenue Next Year
- CVAC $23.83
- DOLE $1.77
- P/E Ratio
- CVAC $5.34
- DOLE $51.77
- Revenue Growth
- CVAC 675.15
- DOLE 4.75
- 52 Week Low
- CVAC $2.37
- DOLE $12.20
- 52 Week High
- CVAC $5.72
- DOLE $16.96
- Technical
- Relative Strength Index (RSI)
- CVAC 45.73
- DOLE 45.18
- Support Level
- CVAC $5.34
- DOLE $12.70
- Resistance Level
- CVAC $5.41
- DOLE $13.20
- Average True Range (ATR)
- CVAC 0.04
- DOLE 0.23
- MACD
- CVAC -0.00
- DOLE 0.02
- Stochastic Oscillator
- CVAC 18.18
- DOLE 56.38
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.